WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
The recent World Health Organization moratorium on rectal artesunate (RAS) for pre-referral treatment of severe childhood malaria is costing young lives. The decision was based on disappointing findings from a large observational study that provided RAS to community health workers with little traini...
Príomhchruthaitheoirí: | Peto, TJ, Watson, JA, White, NJ, Dondorp, AM |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Oxford University Press
2023
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
de réir: Watson, JA, et al.
Foilsithe / Cruthaithe: (2023) -
The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
de réir: Watson, JA, et al.
Foilsithe / Cruthaithe: (2023) -
Rectal artesunate: lives not saved
de réir: White, NJ, et al.
Foilsithe / Cruthaithe: (2024) -
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
de réir: James A Watson, et al.
Foilsithe / Cruthaithe: (2023-11-01) -
Stopping prereferral rectal artesunate - a grave error
de réir: Watson, JA, et al.
Foilsithe / Cruthaithe: (2022)